Two decades after its enactment, India’s ‘sunshine law’ that encodes the Right to Information is losing its power to hold ...

Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...

A research team led by Professor Joshua Rabinowitz of the Department of Chemistry at Princeton University published findings ...

Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

Korea Hydro & Nuclear Power has simultaneously demonstrated pain relief and functional improvement in a clinical trial using ...

A Pitt faculty member is challenging the effectiveness of shared governance at Pitt, arguing the faculty senate has no real ...

Companies have built their security strategies around phishing simulations and educational webinars, tactics that research ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim efficacy data from its ongoing ...

Exclusive IDWeek 2025 coverage on HIV ART regimens, long COVID research, C difficile findings, pneumonia predictors, and more ...

Could a future vaccine against cancer be made better by an immune-boosting virus? Very likely, say Canadian scientists, ...

Theriva Biologics ( ($TOVX) ) has provided an update. On October 20, 2025, Theriva Biologics presented expanded data from their VIRAGE Phase 2b ...